Dechra raises full-year profit, divi

1st Sep 2009 07:22

Dechra Pharmaceuticals, which focuses on the veterinary sector, upped it dividend by 10% as it reported a 38% rise in full-year profit.Pre-tax profit rose to £16.1m in the year ended 30 June compared with £11.7m last time, while revenue increased 15% to £350m.The final dividend has been raised to 6.10 pence per share (2008: 5.50 pence), taking the total dividend for the year to 9.10 pence compared with last year’s 8.25 pence.‘Despite the current uncertain economic outlook, the majority of the markets in which we trade continue to show growth although at a slower rate than historically,’ said the group.‘Within the UK, current market growth has been as a result of price inflation rather than volume growth, with livestock products outperforming the companion animal sector. The Group’s current performance, however, is in line with the Board’s expectations.’